From January to June 2020, companies in the region allocated $71 million for the purchase of human vaccines abroad, and 60% of imports were made by companies in Panama, Guatemala and Honduras.
Figures from the Trade Intelligence Area of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
The business sector in Guatemala is anticipating an increase in the prices of food and medicines, due to the government's decision to raise the cost of procedures such as the issuance of licenses and health registrations, required to market these products.
By means of Government Agreement 179-2020, which entered into force on December 1, 2020, new fees were imposed for the services of procedures for licenses, registrations and other processes for medicines, laboratories, pharmaceuticals, food products and others.
Nicaragua, Costa Rica and Guatemala are the Central American markets that during the first half of 2020 and in year-on-year terms, increased their imports of pharmaceutical products.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
The Social Security bids the ultrasonography services for patients of the institution's peripheral units in Zone 11, Zone 5 and the Outpatient Disease Consultation Unit.
From January to July 2020, purchases of pharmaceutical products made by Central American countries from Mexican companies totaled $174 million, 7% more than what was reported for the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
From January to March 2020, companies in the region bought vaccines for human use abroad for $28 million, and 56% of total imports were made by companies in Costa Rica and Panama.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
The business sector in Guatemala rejects the measure of the Ministry of Economy, which establishes maximum sales prices to the consumer for certain pharmaceutical products, while the state of disaster decreed by covid-19 lasts.
Arguing that the health of the nation's inhabitants is a public good and that institutions are required to ensure its conservation and restoration, the government will regulate the prices of several medicines.
From January to March 2020, pharmaceutical product imports in Central America totaled $825 million, with Costa Rica and Guatemala being the markets where purchases increased the most.
Figures from CentralAmericaData's Commercial Intelligence Unit: [GRAFICA caption="Click to interact with graphic"]
In the case of Costa Rica, a potential for internationalization has been identified in five medical service specialties: orthopedics, fertility, oncology, ophthalmology and bariatric surgery.
A study carried out by the Promotora de Comercio Exterior (Procomer) states that "On a general level of context, it was determined that in all of them (with the exception of fertility) there is evidence of experience in the care of international patients (at least in one procedure)."
Productos Roche, Drogueria e Importadora Alemana and Corporacion Industrial Farmaceutica are some of the companies that during the first six months of the year won contracts to provide medicines and pharmaceutical products to public health institutions in the region.
The "Interactive Public Procurement Information System" of CentralAmericaData's Trade Intelligence Unit provides interesting data on the companies that in the first half of 2020 were favored with contracts to provide pharmaceutical products and medical supplies to the various Ministries of Health and Social Security entities in the Central American countries.
From January to March 2020, purchases of pharmaceutical products made by Central American countries from companies in Mexico totaled $73 million, 2% more than reported in the same period in 2019.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with graphic"]
It is estimated that last year companies from Guatemala, the Dominican Republic and Nicaragua represented 70% of the regional imports of orthopedic articles and appliances.
The "Market Study of Medical Equipment in Central America and the Dominican Republic", prepared by the Trade Intelligence Unit of CentralAmericaData, details the main figures of the regional market for different types of medical equipment.
The U.S. International Development Finance Corporation offered a $250 million quota for companies in the country to invest in health sector projects.
Directors of the International Development Finance Corporation (DFC) were the ones who reported last May 11 the existence of these financial resources. The exclusivity of these $250 million for companies in the health sector is due to the current health emergency situation, which derives from the outbreak of covid-19.
In the complex scenario of health crisis, companies in the pharmaceutical sector in Guatemala are facing shortages of raw materials, mainly those imported from the U.S., Europe and China.
In the context of the covid-19 outbreak, the pharmaceutical industry has kept alive and according to businessmen in the sector, the country's laboratories maintain their operations at an average of 70%.
Operating Company dedicated to the manufacture of gluten-free and sugar-free products, OHNE brand. The OHNE brand has 8 product lines: square bread, sweet...
español
2090